DGX Quest Diagnostics Incorporated

259.10USD-0.16%Mkt Cap: 28.50B USDP/E: 25.81

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing,…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap28.50B USD
Enterprise Value34.57B USD
Revenue (TTM)11.84B USD
Gross Profit3.67B USD
Net Income (TTM)992.00M USD
Revenue/Share108.14 USD
Last Price259.10 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees60.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)25.81
P/E (Forward)21.62
PEG1.68
EV/EBITDA14.70
EV/Revenue2.92
P/S2.41
P/B3.73
EPS (TTM)10.04 USD
EPS (Forward)11.98 USD
52W Range
171.1896% of range263.19
52W High263.19 USD
52W Low171.18 USD
Profitability
Gross Margin33.21%
Oper. Margin14.92%
EBITDA Margin19.86%
Profit Margin8.99%
ROE13.84%
ROA6.11%
ROIC8.81%
ROCE11.16%
Growth
Revenue Growth10.00%
Earnings Growth28.70%
Cash Flow & Leverage
Operating CF1.89B USD
CapEx (TTM)527.00M USD
FCF Margin7.37%
FCF Yield3.06%
Net Debt5.60B USD
Net Debt/EBITDA2.38
Net Debt/FCF6.42
Balance Sheet
Debt/Equity0.92
Current Ratio1.70
Quick Ratio1.37
Book Value/Sh69.38 USD
Cash/Share7.24 USD
Dividends
Fwd Div Rate3.44 USD
Trail. Div Rate3.38 USD
Div. Yield1.32%
5Y Avg Yield1.81%
Payout Ratio25.10%
Ex-Div DateJan 12, 2027
Pay DateJan 27, 2027
Splits
Last Split2:1
Split DateJun 21, 2005
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)257.27 USD
Upside (mean)-0.7%
Target Range235.00 USD – 279.00 USD
235.00-0.7% to mean279.00
# Analysts15
Ownership
Shares Out.110.02M
Float109.44M
Insiders0.47%
Institutions98.40%
Short Interest
Short Ratio3.6d
Short % Float3.40%
Short % Out.3.39%
Shares Short3.73M
Short (prev mo.)3.42M
Technical
SMA 50241.80 (+7.2%)
SMA 200216.08 (+19.9%)
Beta0.55
S&P 52W Chg12.08%
Avg Vol (30d)954.61K
Avg Vol (10d)863.13K
Technical Indicators
RSI (14)62.5
MACD5.3493
MACD Signal5.4125
MACD Hist.-0.0632
BB Upper266.81 USD
BB Middle253.75 USD
BB Lower240.69 USD
BB Width10.29%
ATR (14)5.680 USD
Vol Ratio (20d)1.16x

About Quest Diagnostics (NYSE: DGX)

›

Quest Diagnostics (NYSE: DGX) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 60,000 employees.

The shares were at 259.10 USD on 19 November 2026, up 39.8% over 52 weeks. Its 52-week range is 171.18 USD to 263.19 USD: the price is 1.6% below the high and 51.4% above the low.

At a market capitalisation of 28.50B USD, it trades at 25.8 times trailing earnings and 21.6 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 28% for DGX. It pays a dividend yielding 1.32% (it pays out 25% of its earnings), against a median of 0.73% among the dividend payers in that peer group.

Quest Diagnostics reports return on equity of 13.8%, an operating margin of 14.9% and revenue up 10.0% year over year.

Its debt exceeds its cash by 5.60B USD, a debt-to-equity ratio of 0.92. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 15 analysts cover the stock, with an average rating of Buy; their mean price target of 257.27 USD is 0.7% below the current price. The next earnings report is expected on 9 February 2027.